Momenta Pharmaceuticals (MNTA)

13.83 -0.14  -1.00%  May 30, 8:00PM Go Pro
Watch this stock
View Full Chart MNTA Price Chart

Key Stats

Market Cap 709.89M
Revenue Growth -69.01%
Profit Margin -20.56%
Earnings Yield 16.78%
Dividend Yield 0.00%
Earnings Per Share TTM 2.32
PE Ratio 5.961
Price / Sales Ratio 3.098
52 Week High 20.98
52 Week Low 10.15
Beta 1.356
View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More
  • Pro Value Score Go Pro
  • Pro Fundamental Score Go Pro
  • Pro Valuation from Historical Multiples Go Pro

Profile

Exchange: NASDAQGM       Sector: Healthcare       Industry: Biotechnology

Momenta Pharmaceuticals, Inc. develops and discovers drugs. The company specializes in the detailed structural analysis of complex mixture drugs. It applies its technology to the development of generic versions of complex drugs and novel drugs. The firm also specializes in the characterization and process engineering of complex molecules. These complex molecules include proteins, polypeptides, and cell surface polysaccharides, like heparan-sulfate proteoglycans, or HSPGs. The company was formerly known as Mimeon, Inc. and changed its name to Momenta Pharmaceuticals, Inc. in September 2002. Momenta Pharmaceuticals, Inc. was founded by Ram Sasisekharan and Ganesh Venkatraman in May 2001 and is headquartered in Cambridge, Massachusetts.

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Momenta Pharmaceuticals is down 30.88% over the last year vs S&P 500 Total Return up 0.88%, Albany Molecular Research down 45.73%, and Vanda Pharmaceuticals down 44.24%.

  • MNTA Total Returns
  • ^SPXTR Total Returns
  • AMRI Total Returns
  • VNDA Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Income Statement View Statement

Balance Sheet View Statement

Cash Flow Statement View Statement

Get Quote for

Pro Strategies Featuring MNTA

Did Momenta Pharmaceuticals make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

MNTA Charts

Recent Quotes

Symbol Price Chg Chg % Market Cap
MNTA 13.83 -0.14 -1.00% 709.89M
MNST 73.64 +0.60 +0.82% 12.84B
MNRO 34.12 -0.34 -0.99% 1.053B
MNRK 9.95 +0.00 +0.00% 59.10M
MNR 10.22 +0.04 +0.39% 410.54M
MNOV 1.73 -0.01 -0.75% 27.84M
MNKD 1.83 -0.01 -0.54% 306.47M
MNI 2.19 -0.02 -0.91% 187.05M
MNE 15.25 +0.14 +0.89%
MNDO 1.70 -0.01 -0.58% 31.84M
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close